Analytical and Characterization Studies of Organic Chemicals, Drugs, and Drug Formulation

reportActive / Technical Report | Accession Number: ADA398223 | Open PDF

Abstract:

During the annual contract period, 1 July 2000 to 30 June 2001,the project personnel continued to perform chemicalphysical analyses on bulk pharmaceutical substances and formulated drug products of interest to the USAMRMC Drug Development Program for parasitic and infectious diseases, chemical and biological defense, etc. Specific objectives were to design, develop, validate, and apply methods to determine chemical and physical characterisitics of bulk drugs, drug products, and to determine their stability under defined storage conditions. Special projects include verification of the absence of squalene in vaccine products.

Author(s):
Lim, Peter
Author Organization(s):
SRI INTERNATIONAL MENLO PARK CA
Descriptive Note:
Annual rept. 1 Jul 2000-30 Jun 2001
Pagination:
0008

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release

RECORD

Collection: TR
Identifying Numbers
Contract/Grant Number(s):
DAMD17-97-C-7052
Monitor Series:
USAMRMC
 Subject Terms
Joint Capability Areas:
JCA_5_Command and Control; JCA_5.3_Planning; JCA_4.5.4_Requirements Definition; JCA_4.5_Operational Contract Support; JCA_5.3.3_Develop Strategy; JCA_5.3.4_Develop Courses of Action; JCA_5.3.5_Analyze Courses of Action; JCA_6.4.1_Secure Information Exchange; JCA_1.2.5_Lessons Learned; JCA_8_Building Partnerships
Communities of Interest:
No COI(s) Identified
Descriptor(s):
*CHEMICAL ANALYSIS, *FORMULATIONS(CHEMISTRY), *ANTIPARASITIC DRUGS, DEFENSE SYSTEMS, CHEMICAL PROPERTIES, PHYSICAL PROPERTIES, BIOLOGICAL WARFARE, CHEMICAL WARFARE, INFECTIOUS DISEASES, PHARMACOLOGY, VACCINES, PARASITIC DISEASES
Field(s)/Group(s):
Medicine and Medical Research, Pharmacology, Chemical, Biological and Radiological Warfare
Keyword(s):
STABILITY STUDIES
Report Date:
2001 Jul 01
Creation Date:
2002 Feb 06